Epigral Ltd vs Multibase India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 856.45 as of 18 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Multibase India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Multibase India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Multibase India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

FAQs for the comparison of Epigral Ltd and Multibase India Ltd

Which company has a larger market capitalization, Epigral Ltd or Multibase India Ltd?

Market cap of Epigral Ltd is 3,694 Cr while Market cap of Multibase India Ltd is 358 Cr

What are the key factors driving the stock performance of Epigral Ltd and Multibase India Ltd?

The stock performance of Epigral Ltd and Multibase India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Multibase India Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹856.45. On the other hand, Multibase India Ltd stock price is INR ₹283.8.

How do dividend payouts of Epigral Ltd and Multibase India Ltd compare?

To compare the dividend payouts of Epigral Ltd and Multibase India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.